UCB SA is a biopharmaceutical business that discovers medicines and solutions for people suffering from neurological and immune disorders. The corporation has operations in the United States, Japan, Germany, the rest of Europe, Spain, France, Italy, the United Kingdom, Ireland, China, and Belgium, as well as globally. The company's headquarters are in Brussels, Belgium, where it was formed in 1928.